Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.

Treatment with treprostinil led to significant and sustained improvements in children with PH associated with lung disease, ...

Corvista Health and Mayo Clinic will study whether Corvista-PH can improve pulmonary hypertension diagnosis and referrals.

“This study provides comprehensive preclinical evidence that the novel PDE5 inhibitor CPD1 is a potent therapeutic candidate ...

The analysis revealed dozens of genes with abnormal expression in cells from people with idiopathic PAH, and the researchers ...

World Pulmonary Hypertension Day 2026 highlights hope through clinical trials for the global disease community.

Pulmonary hypertension (PH) is caused by high blood pressure in the lungs, which is caused by narrowed and thickened pulmonary arteries. Because of the added effort needed to pump blood through the ...

Irregular heart rhythms in people with pulmonary arterial hypertension are linked to a greater risk of poor outcomes, a U.S.

Elevated pulmonary vascular resistance (PVR), a measure of how difficult it is for blood to move from the heart to the lungs, was associated with a higher risk of poor outcomes in people with ...

Share this page with email Share this page on Facebook Share this page on X Share this page on Reddit Print Preferred Source on Google Growing up with a rare, chronic illness can draw a lot of ...

Data from smartphones and wearable devices may help with the early detection of idiopathic pulmonary arterial hypertension (IPAH), a rare lung disease with no known cause, a study suggests. Using up ...